Speakers & Presenters

All Speakers

Filter by letter

VICE PRESIDENT, INDUSTRY RESEARCH, BIOTECHNOLOGY INNOVATION ORGANIZATION

BIO's State of VC Investment Trends

Washington, District of Columbia, United States

Marco Taglietti, MD

PRESIDENT & CHIEF EXECUTIVE OFFICER, SCYNEXIS, INC.

SCYNEXIS, Inc.

Jersey City, New Jersey, United States

Ken Takeshita, MD

SENIOR VICE PRESIDENT AND GLOBAL HEAD OF CLINICAL DEVELOPMENT, KITE, A GILEAD COMPANY

Fireside Chat: How Kite Pharma Is Building Out The Promise Of CAR-T To Transform Cancer Treatment

Robert Tarran

FOUNDER/CSO, ELDEC PHARMACEUTICALS

Eldec Pharmaceuticals

Chapel Hill, North Carolina, United States

John Temperato

PRESIDENT & CEO, 9 METERS BIOPHARMA, INC.

9 Meters Biopharma, Inc.

Raleigh, North Carolina, United States

Daniel Teper, MBA, PHARMD

CHAIRMAN & CEO, CYTOVIA THERAPEUTICS, INC.

Cytovia Therapeutics

New York, New York, United States

Nikolaos Tezapsidis, PHD

PRESIDENT & CEO, NEUROTEZ, INC.

Neurotez Inc.

BRIDGEWATER, New Jersey, United States

Brian Toglia

LIFE SCIENCE PRACTICE LEADER, HIGGINBOTHAM

Higginbotham

Houston, Texas, United States

Martin Tolar

FOUNDER, PRESIDENT AND CEO, ALZHEON, INC.

How to Pivot Neurodegeneration Treatment Research?

Framingham, Massachusetts, United States

Philip Toleikis, PHD, MSC

PRESIDENT & CEO, SERNOVA CORP.

Sernova Corp.

London, Ontario, Canada

Vuong Trieu, PHD

CEO, ONCOTELIC, INC.

Mateon Therapeutics

Agoura Hills, California, United States

Karen Tuzman, PHD

HEAD, DISCOVERY & PRECLINICAL RESEARCH, BIOCENTURY INC.

AI's Widening Impact on Drug Development

Redwood City, California, United States